Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02621671 · ClinicalTrials.gov registry record · Phase 1

Communicating Multiple Disease Risks

A Phase 1 study of Healthy, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 1
Development phase
1,191
Enrollment target
1
Study location

NCT02621671: Completed Phase 1 study of Healthy, sponsored by Washington University School of Medicine.

NCT02621671 is a Phase 1 study of Healthy that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,191 participants, above the 646-participant average among 1,090 other Healthy trials with a reported enrollment target (84% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02621671, a Phase 1 study of Healthy, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 1
Development phase
1,191 participants
Enrollment target
1
Study location

Study Summary

Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences. The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health. The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.

Primary Outcome

Survey questions will assess participants' cognitive and affective risk perceptions, response efficacy, perceived severity and reaction to the visual displays, health literacy and numeracy. The quantitative data will be examined using descriptive statistics (e.g., frequencies, mean, median, mode, range, interquartile range, standard deviation) to evaluate whether a potential variability problem exists (e.g., restricted range) .

Conditions Studied

Interventions

  • OTHER Survey
  • BEHAVIORAL Cognitive interview

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 1,191 participants
Start Date 2015-04-01
Est. Completion 2017-06-27
Phase Phase 1

What the finished NCT02621671 record still lists

NCT02621671 is an interventional study that assigns participants to a tested intervention. Its 1,191 participants enrollment target places it among the larger protocols in the corpus, above the 646-participant average among 1,090 other Healthy trials with a reported enrollment target (84% higher).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Survey is the first listed.

NCT02621671 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT02621671 about?

NCT02621671 is a clinical study titled "Communicating Multiple Disease Risks". Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences. The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. ...

What is the current status of trial NCT02621671?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,191 participants. The study started on 2015-04-01. Estimated completion is 2017-06-27.

What conditions does trial NCT02621671 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02621671?

The interventions under investigation include: Survey (OTHER), Cognitive interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT02621671?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02621671 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02621671's enrollment target sits among peer trials

1,191 27th of 1090 higher than 1,064 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

  • NCT07177339 · 1,196 participants · Phase 3

    eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02621671, the US trial registry maintained by the National Library of Medicine. NCT02621671 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.